Blood glucose testing and primary prevention of diabetes mellitus type 2 - evaluation of the effect of evidence based patient information

BMC Public Health

Study Protocol

Jutta Genz¹  Wolfgang Rathmann¹  Guido Giani¹  Andrea Icks¹  Michael Roden²  Bettina Nowotny²  Christian Ohmann³  Andreas Mielck⁴  Burkhard Haastert⁵  Anke Steckelberg⁶  Frank Verheyen⁷  Hardy Müller⁷  Dennis Cole⁷  Gabriele Meyer⁸ 

[1] German Diabetes-Centre, Leibniz Institute at Heinrich Heine University Düsseldorf, Institute of Biometrics and Epidemiology, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany;German Diabetes-Centre, Leibniz Institute at Heinrich Heine University Düsseldorf, Institute of Clinical Diabetology, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany;Heinrich-Heine-University Düsseldorf, Coordination Centre for Clinical Trials (KKS), Moorenstr. 5, 40225, Düsseldorf, Germany;Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Health Economics and Health Care Management, P.O. Box 1129, 85758, Neuherberg, Germany;Medistatistica, Lambertusweg 1b, 58809, Neuenrade, Germany;University of Hamburg, MIN Faculty, Health Sciences, Hamburg, Germany;WINEG - Scientific Institute for Benefit and Efficiency in Health Care, Habichtstraße 30, 22305, Hamburg, Germany;Witten/Herdecke University, Faculty of Medicine, Institute of Nursing Sciences, Stockumer Straße 12, 58453, Witten, Germany;

关键词: Life Satisfaction;    Impaired Fasting Glucose;    Elevated Blood Glucose;    Subjective Social Status;    Blood Glucose Test;   

DOI  :  10.1186/1471-2458-10-15

 received in 2009-12-15, accepted in 2010-01-14,  发布年份 2010

来源: Springer

【 摘 要 】

BackgroundEvidence-based patient information (EBPI) has been recognised as important tool for informed choice in particular in the matter of preventive options. An objective, on the best scientific evidence-based consumer information about subthreshold elevated blood glucose levels (impaired fasting glucose and impaired glucose tolerance) and primary prevention of diabetes, is not available yet. Thus we developed a web-based EBPI and aim to evaluate its effects on informed decision making in people 50 years or older.Methods/DesignWe conduct a web-based randomised-controlled trial to evaluate the effect of information about elevated blood glucose levels and diabetes primary prevention on five specific outcomes: (i) knowledge of elevated blood glucose level-related issues (primary outcome); (ii) attitudes to a metabolic testing; (iii) intention to undergo a metabolic testing; (iv) decision conflict; (v) satisfaction with the information. The intervention group receives a specially developed EBPI about subthreshold elevated blood glucose levels and diabetes primary prevention, the control group information about this topic, available in the internet.The study population consists of people between 50 and 69 years of age without known diabetes. Participants will be recruited via the internet page of the cooperating health insurance company, Techniker Krankenkasse (TK), and the internet page of the German Diabetes Centre. Outcomes will be measured through online questionnaires. We expect better informed participants in the intervention group.DiscussionThe design of this study may be a prototype for other web-based prevention information and their evaluation.Trial registrationCurrent Controlled Trial: ISRCTN22060616.

【 授权许可】

CC BY   
© Genz et al; licensee BioMed Central Ltd. 2010